# HURN — AI stock forecast & analysis

> AI-generated analysis by K3vl4r — 2026-07-01. Informational only, not financial advice.

**Recommendation:** ACCUMULATE

**Scores (0–100):** Overall 5.8 · Fundamentals 6 · Technicals 3 · Growth 6.5 · Risk 7.5

## Summary

Huron has been cut in half from its early-2026 peak of ~$186 to $90, trading at 8.8x forward EPS despite double-digit revenue growth and 23% ROE — a valuation reset that reflects genuine concerns (debt/equity 2.24x, Q1 FCF swung to -$174M, YTD -48%) rather than mispricing alone. The setup offers asymmetric mean-reversion potential given depressed multiple and $184 sell-side target, but the trend is broken (price -37% vs 200SMA, RSI 35, fresh 52-week lows) and the forecast model has been unreliable, so this is a patient accumulation, not a chase.

## Price targets (12-month horizon)

- Bear: $75.00
- Base: $108.00
- Bull: $135.00

## News context

The narrative is bifurcated. Positive signals include the RelateCare acquisition adding AI-enabled healthcare managed services (consistent with the stated diversification thesis), record Q1'26 revenue of $443.7M+ (+12.1% YoY) with full-year guidance reaffirmed, and a Zacks note flagging 7.1% single-session strength. Analyst posture remains constructive on paper — average recom of 1.00 (strong buy) and $184 target implies 100%+ upside — but Truist just cut its price target from $240 to $155 on June 9, a meaningful reset even while maintaining Buy. StockStory's 'explosive upside' framing and insider selling coverage indicate the stock is now firmly a value/turnaround debate. The signal: operating fundamentals are intact and management is executing on strategy, but the sell-side is quietly walking down expectations while the price prices in something worse than the reported results.

## About
- Methodology: https://app.k3vl4r.com/methodology
- Full report: https://app.k3vl4r.com/r/hurn-ai-stock-forecast-45bc378ace52bed2c7559cd2195c2369
- AI-generated; model outputs can be wrong. Not financial advice.